<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">2746</id>
  <title>T3D2704</title>
  <common-name>Menadione</common-name>
  <description>Menadione is a synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo. Despite the fact that it can serve as a precursor to various types of vitamin K, menadione is generally not used as a nutritional supplement. Large doses of menadione have been reported to cause adverse outcomes including hemolytic anemia due to G6PD deficiency, neonatal brain or liver damage, or neonatal death in some cases. Moreover, menadione supplements have been banned by the FDA because of their high toxicity. It is sometimes called vitamin K3, although derivatives of naphthoquinone without the sidechain in the 3-position cannot exert all the functions of the K vitamins. Menadione is a vitamin precursor of K2 which utilizes alkylation in the liver to yield menaquinones (MK-n, n=1-13; K2 vitamers), and hence, is better classified as a provitamin.</description>
  <cas>58-27-5</cas>
  <pubchem-id>4055</pubchem-id>
  <chemical-formula>C11H8O2</chemical-formula>
  <weight>172.052430</weight>
  <appearance>White powder.</appearance>
  <melting-point>107°C</melting-point>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility>160 mg/L (at 30°C)</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Variable and ranges from 10% to 80%</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>Menadione (vitamin K3) is involved as a cofactor in the posttranslational gamma-carboxylation of glutamic acid residues of certain proteins in the body. These proteins include the vitamin K-dependent coagulation factors II (prothrombin), VII (proconvertin), IX (Christmas factor), X (Stuart factor), protein C, protein S, protein Zv and a growth-arrest-specific factor (Gas6). In contrast to the other vitamin K-dependent proteins in the blood coagulation cascade, protein C and protein S serve anticoagulant roles. The two vitamin K-dependent proteins found in bone are osteocalcin, also known as bone G1a (gamma-carboxyglutamate) protein or BGP, and the matrix G1a protein or MGP. Gamma-carboxylation is catalyzed by the vitamin K-dependent gamma-carboxylases. The reduced form of vitamin K, vitamin K hydroquinone, is the actual cofactor for the gamma-carboxylases. Proteins containing gamma-carboxyglutamate are called G1a proteins.</mechanism-of-toxicity>
  <metabolism>Hepatic</metabolism>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>3, not classifiable as to its carcinogenicity to humans. (L135)</carcinogenicity>
  <use-source>The primary known function of vitamin K is to assist in the normal clotting of blood, but it may also play a role in normal bone calcification.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms>Menadione (vitamin K3), which is not used as a nutritional supplemental form of vitamin K for humans, has been reported to cause adverse reactions, including hemolytic anemia. Large doses have also been reported to cause brain damage.</symptoms>
  <treatment nil="true"/>
  <created-at type="dateTime">2009-07-21T20:26:13Z</created-at>
  <updated-at type="dateTime">2026-05-14T16:24:26Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Menadione</wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id>C05377</kegg-compound-id>
  <omim-id>109135
112260
113811
115430
118650
122700
137167
138140
154870
176860
176880
176930
188055
192090
204690
214900
215100
219700
227220
227500
227600
245150
252650
261515
277450
302960
305900
306900
310400
600424
600441
600646
601841
602421
602497
604428
604429
604824
605271
607473
607542
607748
608547
608838
610842</omim-id>
  <chebi-id>28869</chebi-id>
  <biocyc-id>CPD-3766</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id>Menadione</stitch-id>
  <drugbank-id>DB00170</drugbank-id>
  <pdb-id>VK3</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1=CC(=O)C2=CC=CC=C2C1=O</moldb-smiles>
  <moldb-formula>C11H8O2</moldb-formula>
  <moldb-inchi>InChI=1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3</moldb-inchi>
  <moldb-inchikey>MJVAVZPDRWSRRC-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">172.18</moldb-average-mass>
  <moldb-mono-mass type="decimal">172.0524295</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp>2.2</logp>
  <hmdb-id>HMDB01892</hmdb-id>
  <chembl-id>CHEMBL590</chembl-id>
  <chemspider-id>3915</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Joachim U. Schneider, Hans Kiefer, &amp;#8220;Menadione choline bisulfite adduct, its preparation and antihemorrhagic compositions.&amp;#8221; U.S. Patent US4735969, issued January, 1980.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM002136</chemdb-id>
  <dsstox-id>DTXSID4021715</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00010106</susdat-id>
  <iupac>2-methyl-1,4-dihydronaphthalene-1,4-dione</iupac>
  <moldb-polar-surface-area>34.14</moldb-polar-surface-area>
  <moldb-refractivity>50.5403</moldb-refractivity>
  <moldb-polarizability>17.637158614910383</moldb-polarizability>
  <moldb-rotatable-bond-count>0</moldb-rotatable-bond-count>
  <moldb-acceptor-count>2</moldb-acceptor-count>
  <moldb-donor-count>0</moldb-donor-count>
  <moldb-pka-strongest-acidic>12.936644003276722</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>-7.157932075900291</moldb-pka-strongest-basic>
  <moldb-physiological-charge>0</moldb-physiological-charge>
  <moldb-number-of-rings>2</moldb-number-of-rings>
  <moldb-alogps-logp>1.91</moldb-alogps-logp>
  <moldb-alogps-logs>-2.53</moldb-alogps-logs>
  <moldb-alogps-solubility>5.04e-01 g/l</moldb-alogps-solubility>
</compound>
